Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-04

Clinical Trial Update: Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of combining alogliptin with pioglitazone in adults with Type 2 Diabetes Mellitus; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actos (Pioglitazone)
  • Nesina (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-04-04